Silence Therapeutics plc (OTCMKTS:SLNCF – Get Free Report)’s share price dropped 7.2% during trading on Tuesday . The company traded as low as $6.22 and last traded at $6.22. Approximately 404 shares changed hands during mid-day trading, a decline of 76% from the average daily volume of 1,696 shares. The stock had previously closed at $6.70.
Silence Therapeutics Stock Performance
The company has a 50 day moving average price of $6.49 and a two-hundred day moving average price of $7.19.
About Silence Therapeutics
Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development novel molecules incorporating short interfering ribonucleic acid (siRNA) to inhibit the expression of specific target genes in hematology, cardiovascular, and rare diseases. The company's mRNAi GalNAc Oligonucleotide Discovery platform consists of precision engineered product candidates designed to target specific disease-associated genes in the liver.
See Also
- Five stocks we like better than Silence Therapeutics
- What Are Dividend Achievers? An Introduction
- Rocket Lab Stock Soars: Should Investors Chase the Rally?
- Conference Calls and Individual Investors
- KB Home Slips After Earnings: What’s Next for Homebuilders?
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Micron Stock Soars as AI Demand Fuels Big Q4 Earnings Beat
Receive News & Ratings for Silence Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Silence Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
